| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T647 |
0-67 |
Sentence |
denotes |
Table 5 Vaccine Candidates Currently Registered for Clinical Trials |
| T648 |
68-141 |
Sentence |
denotes |
Candidate Design Developer Similar Strategy ClinicalTrials.gov Identifier |
| T649 |
142-271 |
Sentence |
denotes |
mRNA-1273 LNP-encapsulated mRNA for full-length S protein ModernaTX CMV (John et al., 2018), ZKV (Pardi et al., 2017) NCT04283461 |
| T650 |
272-453 |
Sentence |
denotes |
BNT162a1, b1, b2, c2 LNP-encapsulated mRNA vaccines with different formats of RNA and targets, two for larger S sequence and two for optimized RBD BioNTech SE and Pfizer NCT04368728 |
| T651 |
454-597 |
Sentence |
denotes |
INO-4800 DNA vaccine for full-length S protein Inovio Pharmaceuticals MERS-CoV (Modjarrad et al., 2019), HPV (Trimble et al., 2015) NCT04336410 |
| T652 |
598-758 |
Sentence |
denotes |
Ad5-nCoV adenovirus type 5 encoding full-length S protein CanSino Biologics EBV (Zhu et al., 2015, Zhu et al., 2017) NCT04313127 (phase I)NCT04341389 (phase II) |
| T653 |
759-910 |
Sentence |
denotes |
ChAdOx1 nCoV-19 adenovirus encoding full-length S protein University of Oxford MERS-CoV (Alharbi et al., 2017), IAV (Antrobus et al., 2014) NCT04324606 |
| T654 |
911-1109 |
Sentence |
denotes |
COVID-19 LV-SMENP-DC dendritic cells infected with lentivirus expressing SMENP minigenes to express COVID-19 antigens, together with activated CTLs Shenzhen Geno-Immune Medical Institute NCT04276896 |
| T655 |
1110-1256 |
Sentence |
denotes |
COVID-19 aAPCs aAPCs infected with lentivirus expressing minigenes to express COVID-19 antigens Shenzhen Geno-Immune Medical Institute NCT04299724 |
| T656 |
1257-1404 |
Sentence |
denotes |
bacTRL-Spike-1 live bacteria delivering plasmid encoding S protein Symvivo Corporation therapeutics reviewed (Charbonneau et al., 2020) NCT04334980 |
| T657 |
1405-1512 |
Sentence |
denotes |
PiCoVacc inactivated SARS-CoV-2 vaccine Sinovac Biotech HAV, IAV, IBV, poliovirus, rabies virus NCT04352608 |
| T658 |
1513-1615 |
Sentence |
denotes |
SARS-CoV-2 rS spike protein nanoparticle vaccine with or without Matrix-M adjuvant Novavax NCT04368988 |
| T659 |
1616-1840 |
Sentence |
denotes |
aAPCs, artificial antigen-presenting cells; CMV, cytomegalovirus; EBV, Ebola virus; HAV, hepatitis A virus; HPV, human papillomavirus; IAV, influenza A virus; IBV, influenza B virus; LPN, lipid nanoparticle; ZKV, Zika virus. |
